Keros Therapeutics, Inc.KROSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
5 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -25.33% |
| 2024 | 28.37% |
| 2023 | 55.00% |
| 2022 | 58.25% |
| 2021 | 62.86% |
| 2020 | 94.83% |
| 2019 | 71.88% |
| 2018 | 0.00% |